enerisant (TS-091) / Taisho  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
enerisant (TS-091) / Taisho
NCT04631276: Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subjects

Completed
1
12
Japan
TS-091
Taisho Pharmaceutical Co., Ltd.
Healthy Subjects
12/15
12/15

Download Options